ENTITY

Crystalgenomics Inc (083790 KS)

Analysis

Health Care • South Korea

CrystalGenomics Incorporation develops pharmaceutical and agricultural products by structure-based drug discovery technology. The Company also provides structural proteomic analysis services for helping drug discovery process.

Refresh

No presentations found

We’ll display presentations we find for Crystalgenomics Inc here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00